Evaluating hormone levels in obese men
Official title: Studio Del Milieu Steroideo in Pazienti Obesi
Run by Istituto Auxologico Italiano · NCT06341699 · Data updated 2026-11-12
This study is testing how hormone levels in obese men affect their bone health and heart disease risk.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | Men only |
| Enrollment | 180 (estimated) |
| Sponsor | Istituto Auxologico Italiano Academic / other |
| Locations | 1 site (Oggebbio, Verbania) |
| Status | Recruiting |
| Started | May 16, 2023 |
| Main results expected | June 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | May 13, 2025 |
| Trial ID | NCT06341699 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are male patients aged 18-80 years with severe obesity and no other known causes of hormonal imbalances.
✕Probably not a fit
Patients with severe systemic diseases, those using corticosteroids, or individuals with specific hormonal pathologies will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess cortisol and testosterone secretion in obese male patients, along with their receptor sensitivity to these hormones. The research will explore the relationship between these hormonal levels and their impact on bone metabolism, lipoprotein function, and the severity of obesity-related complications. Additionally, the study will investigate whether these hormonal factors can predict cardiovascular disease in this population. Data will be collected through questionnaires and blood tests, with analysis conducted at a centralized laboratory.
Why it matters
Potential benefit: If successful, this study could provide insights into hormonal influences on obesity and related health risks, potentially guiding future treatments.
How similar studies have gone: While there have been studies on hormonal influences in obesity, this specific approach focusing on the interplay of cortisol and testosterone in morbidly obese men is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * morbid obesity Exclusion Criteria: * patients suffering from severe systemic pathologies, fever, chronic inflammatory states known to cause PCR \>10 mg/dL * use of corticosteroids at the time of enrollment * the patient's poor understanding of spoken and written Italian * patients suffering from primary pathologies of the testicle, known at enrollment * patients suffering from hypothalamic-pituitary or adrenal pathologies already known at the time of enrollment
Where it's running
-
Istituto Auxlogico Italiano, Hospital San Giuseppe, Piancavallo
Oggebbio, Verbania, Italy Recruiting
Study contacts
- Study coordinator: Biagio Cangiano, MD
- Email: b.cangiano@auxologico.it
- Phone: 3343177491
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Glycemic variability after SASI versus Roux-en-Y gastric bypass
This trial tests whether SASI or Roux-en-Y gastric bypass leads to different glucose fluctuations in adults with severe obesity using continuous glucose monitoring.
-
Postoperative nausea, vomiting and pain after bariatric surgery in Sweden
This study looks at how often people have nausea, vomiting, and pain after bariatric surgery in Sweden and whether anesthesia type or regional blocks affect those outcomes.
-
Low-impact laparoscopy for sleeve gastrectomy in adults with obesity
This will see if low-pressure, small-incision laparoscopy reduces post-surgery pain and improves breathing after sleeve gastrectomy in adults with obesity.
-
Tranexamic acid to reduce bleeding in sleeve gastrectomy and mini gastric bypass
This trial will test whether giving tranexamic acid before laparoscopic sleeve gastrectomy or mini gastric bypass reduces bleeding in adults with morbid obesity.
-
Predicting Quality of Life After Bariatric Surgery from Pre-Surgery Profiles
This study tests whether pre-surgical patient traits can predict how quality of life changes after bariatric surgery for adults in the GEROM73 program.
-
Endoscopic treatment for overweight and mild obesity using Orbera365
This study is testing whether the Orbera365 intragastric balloon can help people who are overweight or mildly obese lose weight over a year.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.